Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Poor adherence to medicines in clinical trials can undermine the value of the trials; for example, by compromising estimates of the benefits and risks of a medicine. In this article, we highlight such consequences and also discuss approaches to tackle this problem.

Original publication

DOI

10.1038/nrd.2017.1

Type

Journal article

Journal

Nature Reviews Drug Discovery

Publication Date

01/03/2017

Volume

16

Pages

149 - 150